Showing results (151-160 of 164) with videos related to
Sort By:
Pageof 17
Magnetic Resonance Imaging|April 24, 1999
MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjectsG Bartzokis, J L Cummings, C H Markham, et al.The American Journal of Psychiatry|December 1, 1996
Two-year outcome of social skills training and group psychotherapy for outpatients with schizophreniaS R Marder, W C Wirshing, J Mintz, et al.The American Journal of Psychiatry|August 1, 1982
d-Amphetamine-induced heterogeneous changes in psychotic behavior in schizophreniaD P van Kammen, W E Bunney, J P Docherty, et al.Optics Letters|November 17, 2007
Photorefractive polymers sensitized by two-photon absorptionP A Blanche, B Kippelen, A Schülzgen, et al.Psychological Medicine|December 23, 2017
Childhood adversity and cognitive function in schizophrenia spectrum disorders and healthy controls: evidence for an association between neglect and social cognitionS Kilian, L Asmal, B Chiliza, et al.The Journal of Clinical Psychiatry|December 1, 1996
Predictive value of eosinophilia for neutropenia during clozapine treatmentD Ames, W C Wirshing, R W Baker, et al.Nature Communications|April 16, 2015
Efficient light emission from inorganic and organic semiconductor hybrid structures by energy-level tuningR Schlesinger, F Bianchi, S Blumstengel, et al.Science (New York, N.Y.)|May 23, 1997
Large molecular third-order optical nonlinearities in polarized carotenoidsS R Marder, W E Torruellas, M Blanchard-Desce, et al.Science (New York, N.Y.)|May 27, 1983
Dopamine-beta-hydroxylase activity and homovanillic acid in spinal fluid of schizophrenics with brain atrophyD P van Kammen, L S Mann, D E Sternberg, et al.Archives of General Psychiatry|November 1, 2001
Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparisonJ M Kane, S R Marder, N R Schooler, et al.Pageof 17